
Join to View Full Profile
Knoxville TNKnoxville, TN 37922
Dr. Ramchandren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Neurologist and Neuromuscular specialist. Former academic director of MDA and CMT center of excellence clinics, specializing in rare genetic and autoimmune diseases. Currently Executive Medical Director of Clinical Research and Development at Johnson and Johnson.
Education & Training
- University of Michigan Medical SchoolMSc, Clinical Research Design and Statistical Analysis, 2005 - 2007
- Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 2004 - 2005
- University of Pennsylvania Health SystemResidency, Neurology, 2000 - 2004
- McGovern Medical School at UTHealthClass of 2000
- University of PittsburghBachelor's, Philosophy in Neuroscience and Classics, Summa Cum Laude, 1992 - 1996
Certifications & Licensure
- MI State Medical License 2004 - 2023
- American Board of Psychiatry and Neurology Neurology
- American Board of Electrodiagnostic MedicineElectrodiagnostic Medicine (EMG)
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Nancy Newton Loeb Pediatric Oncology Award University of Michigan, 2007
- National Research Service Award for Training in Clinical Research University of Michigan, 2005
- Join now to see all
Clinical Trials
- Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others Start of enrollment: 2010 Apr 01
- Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT Start of enrollment: 2010 Apr 01
- Development and Validation of a Disability Severity Index for CMT Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- 1 citationsSafety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study.Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, Richard J Nowak, Constantine Farmakidis
The Lancet. Neurology. 2025-02-01 - Parent-proxy pediatric CMT quality of life outcome measure: Validation of the Italian version.Federica Rachele Danti, Emanuela Pagliano, Davide Pareyson, Maria Foscan, Alessia Marchi
Journal of the Peripheral Nervous System. 2024-03-01 - 9 citationsSafety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG StudyCarlo Antozzi, Jeffrey Guptill, Vera Bril, Josep Gamez, Sven G Meuth
Neurology. 2024-01-23
Journal Articles
- Anterior Tibialis Compound Muscle Action Potential Amplitude Correlations with Impairment in CMT1AKomyathy K, Neal S, Feely S, Miller LJ, Lewis RA, Trigge G, Siskind CE, Shy ME, Ramchandren S, Muscle and Nerve, 4/1/2013
- Focal Peripheral Neuropathies - Book ReviewPuntambekar P, Ramchandren S, Journal of the Neurological Sciences, 1/1/2011
- Heat Shock Proteins HSP70 and HSP27 in the Cerebral Spinal Fluid of Patients undergoing Thoracic Aneurysm Repair Correlate with the Possibility of Postoperative ParalysisHecker JG, Sundram H, Zou S, Praestgard A, Bavaria JE, Ramchandren S, McGarvey M, Cell Stress Chaperones, 1/1/2008
- Join now to see all
Press Mentions
- Nipocalimab Demonstrates Sustained Disease Control in Adolescents Living with Generalised Myasthenia Gravis in the Phase 2/3 StudyOctober 16th, 2024
- Nipocalimab Demonstrates Sustained Disease Control in Adolescents Living with Generalized Myasthenia Gravis in Phase 2/3 StudyOctober 15th, 2024
- AAN Members Only: Sign in with Your AAN Member Credentials (Email or 6-Digit Member ID Number)January 10th, 2017
Professional Memberships
- Member
Industry Relationships
- Director, Clinical Leader-CNS, The Janssen Pharmaceutical Companies of Johnson & Johnson2021 - Present
External Links
- Linkedinhttps://www.linkedin.com/in/sindhu-ramchandren-665b72a2
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: